Coherus BioSciences Inc (CHRS) — Free Cash Flow Generation Index
Coherus BioSciences Inc (CHRS) has a Free Cash Flow Generation Index of 1.00x as of December 2024. Free cash flow of $28.61 Million represents 1% of operating cash flow ($28.61 Million). Read total liabilities of Coherus BioSciences Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Coherus BioSciences Inc Free Cash Flow Generation Index (2013–2020)
Historical FCF Generation Index trend for Coherus BioSciences Inc across 3 annual periods. Explore CHRS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Coherus BioSciences Inc (2013–2020)
Year-by-year Free Cash Flow Generation Index for Coherus BioSciences Inc. For the full company profile including market capitalisation, see Coherus BioSciences Inc stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.95x | $146.91 Million | $154.15 Million | $7.23 Million | ▲ +74.8% |
| 2019 | 0.55x | $15.46 Million | $28.36 Million | $12.90 Million | ▼ -44.1% |
| 2013 | 0.98x | $15.05 Million | $15.42 Million | $373.00K | — |